The Roundtable white paper highlights policy approaches and recommendations for prescribing opportunities, improving community-based access, and developing a path to treatment and recovery.
Briefing sponsored by CEPOP, Biocom and BD explores integrated technology solutions to promote healthcare worker and patient safety.
CEPOP convened a wide-array of stakeholders around the issue of fraudulent and unethical activities in the substance use disorder (SUD) treatment and recovery space.
On Tuesday, July 18, the Collaborative for Effective Prescription Opioid Policies convened a roundtable discussion in Washington, D.C. on barriers to access for medication-assisted treatment (MAT) of opioid use disorder.
On March 7, CEPOP and BD held an Acute Care Opioid Safety and Diversion Prevention Roundtable in Washington, D.C. An array of stakeholders with experience from the clinical and governmental perspectives came together in a structured, full-day dialogue.
